Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 1, 2015, Pages 225-230

  Torner, Nuria ^a,b,c   Martínez, Ana ^a   Basile, Luca ^a   Marcos, M Angeles ^d   Antón, Andrés ^e   Mosquera, M Mar ^d   Isanta, Ricard ^d   Cabezas, Carmen ^a   Jané, Mireia ^a   Dominguez, Angela ^b,c   Aizpurua, P ^f   Alonso, J ^f   Azemar, J ^f   Basas, D ^f   Besora, R ^f   Callado, M ^f   Casanovas, J M ^f   Cid, A ^f   Ciurana, E ^f   Cots, J M ^f   De La Rica, D ^f   Elizalde Del Rio, G ^f   Estabanell, A ^f   Fau, E ^f   Fernandez, O ^f   Ferrer, C ^f   Forcada, A ^f   Forga, F X ^f   Fos, E ^f   Gadea, G ^f   Garcia, J ^f   Garrido, P ^f   Gatius, C ^f   Grive M ^f   Guzman, M C ^f   Hernandez, R ^f   Juscafresa, D ^f   Leon, I ^f   Macia, E ^f   Mainou, A ^f   Marco, E ^f   Martinez, M ^f   Martinez, E ^f   Molinero, C ^f   Moncosi, X ^f   Lopez Mompo C ^f   Naranjo, M A ^f   Navarro, D ^f   Ortola, M E ^f   Perez M C ^f   Perez, M M ^f   Prat, M ^f   Pujol, R ^f   Pujol, J ^f   Ribatallada, A ^f   Sanchez R ^f   Sarra, N ^f   Teixidor, A ^f   Valen, E ^f   Valencia, I ^f   Van Esso, D ^f   Vila, C ^f   Zabala, E ^f   Zurilla, E ^f   more..

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f NONE

Author keywords

Human influenza; Influenza vaccine; Pandemic influenza sentinel surveillance; Seasonal influenza; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; ORTHOMYXOVIRIDAE; PRESCHOOL CHILD; PROCEDURES; SENTINEL SURVEILLANCE; TREATMENT OUTCOME; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; SENTINEL SURVEILLANCE; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 84949120888     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.36155     Document Type: Conference Paper

References (35)

1. Handa R, Teo S, Booy R. Influenza: current evidence and informed predictions. Expert Rev Vaccines 2004; 3:443-51; PMID:15270649; http://dx.doi.org/10.1586/14760584.3.4.443
2. Public Health Agency of Catalonia, Immunization Program. Technical guidelines for seasonal influenza immunization.[cited 2014 Mar 15] Available from. URL: http://www20.gencat.cat/portal/site/canalsalut
3. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28:7381-8; PMID:20851086; http://dx.doi.org/10.1016/j.vaccine.2010.09.010
4. Shim E, Galvani AP. Distinguishing vaccine efficacy and effectiveness. Vaccine 2012; 30:6700-5; PMID:22944629; http://dx.doi.org/10.1016/j.vaccine.2012.08.045
5. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055-68; PMID:3879673
6. Halloran ME. Overview of vaccine field studies: types of effects and designs. J Biopharm Stat 2006; 16:415-27; PMID:16892904; http://dx.doi.org/10.1080/10543400600719236
7. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009; 4:e5079; PMID:19333374; http://dx.doi.org/10.1371/journal.pone.0005079
8. Surveillance and Response to Emergencies in Public Health, Public Health Agencyu of Catalonia. Pla d'informació de les infeccions respiratòries agudes a Catalunya PIDIRAC.[cited 2014 Apr 1]; Available from. URL: http://www20.gencat.cat/portal/site/canalsalut
9. Torner N, Baricot M, Martínez A, Toledo D, Godoy P, Dominguez Á; Influenza Sentinel Surveillance Primary care physicians' Network of Catalonia (PIDIRAC). Influenza sentinel surveillance network: a public health-primary care collaborative action to assess influenza A(H1N1)pmd09 in Catalonia, Spain. Hum Vaccin Immunother 2013; 9:671-4; PMID:23396181; http://dx.doi.org/10.4161/hv.23264
10. Torner N, Morteruel M, Martinez A, Basile L, Isanta R, Pumarola T. Differences in sentinel influenza confirmed incidence rates and clinical presentation of influenza virus: 2008-09 seasonal vs 2009-10 pandemic influenza. Hum Vaccin 2011; 7(Suppl):230-3; PMID:21285535; http://dx.doi.org/10.4161/hv.7.0.14612
11. Centers for Disease Control and Prevention (CDC). Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep 2013; 62:119-23; PMID:23425960
12. McMenamin J, Andrews N, Robertson C, Fleming D, Durnall H, von Wissmann B, Ellis J, Lackenby A, Cottrell S, Smyth B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill 2013; 18:18; PMID:23399421
13. Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, Winter AL, Hottes TS, Fonseca K, Charest H, et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012; 205:1858-68; PMID:22492921; http://dx.doi.org/10.1093/infdis/jis283
14. Jimenez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, Garcia-Cenoz M, Castilla J, Sancho R, Etxebarriarteun-Aranzabal L, Quinones C, et al.; Spanish Influenza Sentinel Surveillance System (SISS). Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill 2014; 19:19; PMID:24626206; http://dx.doi.org/10.2807/1560-7917.ES2014.19.9.20727
15. Plans-Rubió P. The vaccination coverage required to establish herd immunity against influenza viruses. Prev Med 2012l; 55:72-7; PMID:22414740; http://dx.doi.org/10.1016/j.ypmed.2012.02.015
16. World Health Organization (WHO). Prevention and control of influenza pandemics and annual epidemics. 2003. Report No.: WHA56.19.
17. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007; 25:6852-62; PMID:17719149; http://dx.doi.org/10.1016/j.vaccine.2007.07.027
18. Boni MF. Vaccination and antigenic drift in influenza. Vaccine 2008; 26(Suppl 3):C8-14; PMID:18773534; http://dx.doi.org/10.1016/j.vaccine.2008.04.011
19. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
20. Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, Chamorro J, Ortega MT, Albéniz E, Pozo F, et al.; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill 2014; 19:19; PMID:24556347; http://dx.doi.org/10.2807/1560-7917.ES2014.19.6.20700
21. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014; 9:e92153; PMID:24667168; http://dx.doi.org/10.1371/journal.pone.0092153
22. Skowronski DM, Janjua NZ, De Serres G. Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm. Clin Infect Dis 2013; 57:476-7; PMID:23619812; http://dx.doi.org/10.1093/cid/cit256
23. Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, et al.; US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9; PMID:22843783; http://dx.doi.org/10.1093/cid/cis574
24. Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, et al.; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013; 18:18; PMID:23399423
25. Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med 2010; 363:2036-44; PMID:21083388; http://dx.doi.org/10.1056/NEJMra1002842
26. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010; 28:7267-72; PMID:20832494; http://dx.doi.org/10.1016/j.vaccine.2010.08.088
27. Nichol KL. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine 2009; 27:6305-11; PMID:19840665; http://dx.doi.org/10.1016/j.vaccine.2009.07.006
28. Castilla J, Godoy P, Domínguez A, Martínez-Baz I, Astray J, Martín V, Delgado-Rodríguez M, Baricot M, Soldevila N, Mayoral JM, et al.; CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013; 57:167-75; PMID:23532475; http://dx.doi.org/10.1093/cid/cit194
29. Ridenhour BJ, Campitelli MA, Kwong JC, Rosella LC, Armstrong BG, Mangtani P, Calzavara AJ, Shay DK. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One 2013; 8:e76318; PMID:24146855; http://dx.doi.org/10.1371/journal.pone.0076318
30. Valenciano M, Kissling E; I-MOVE Case-Control Study Team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013; 18:3; PMID:23449183
31. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013; 18:18; PMID:23399425
32. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67; PMID:19086915; http://dx.doi.org/10.1086/595861
33. Puig-Barberà J, Díez-Domingo J, Varea AB, Chavarri GS, Rodrigo JA, Hoyos SP, Vidal DG. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007; 25:7313-21; PMID:17889411; http://dx.doi.org/10.1016/j.vaccine.2007.08.039
34. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31; PMID:17403908; http://dx.doi.org/10.1093/ije/dym021
35. European Centers for Disease Control. Influenza case definition. [cited 2014 Jun 1]; Available from: URL: http://ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/influenza-case-definitions.aspx